Company / Free Cash Flow
AGIOS PHARMACEUTICALS, INC. Free Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow
-$377.3M
FY2025
5-year range
-$413.1M / -$297.1M
FY2021-FY2025
Trend
+3.6%
vs FY2024
Sector context
#179 of 194
Health Care
What the data says
Among 194 Health Care companies, AGIOS PHARMACEUTICALS, INC. is in the bottom 8% for free cash flow. Free Cash Flow has fluctuated over the past 10 years, ranging from -$413M in FY2021 to $29M in FY2018.
Based on SEC 10-K filings.
-$377M in FY2025.
Declined from -$297M to -$377M over the past 2 years.
Health Care sector context is included.
Free Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 8% in Health CareTop 92% of 194This company -$377.3M Sector average $470.8M
▼
-180.1% below sector average
Key checks
Key Insights
- In FY2025, free cash flow increased 3.6% year-over-year.
- Ranks #179 out of 194 companies in the Health Care sector.
- Peak free cash flow was recorded in FY2018.
- Lowest free cash flow in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.83 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$377.3M | +3.6% |
| FY2024 | -$391.5M | -31.8% |
| FY2023 | -$297.1M | +2.6% |
| FY2022 | -$304.9M | +26.2% |
| FY2021 | -$413.1M | -32.6% |
| FY2020 | -$311.4M | +18.6% |
| FY2019 | -$382.6M | -1435.7% |
| FY2018 | $28.6M | +109.9% |
| FY2017 | -$289.9M | -1111.8% |
| FY2016 | $28.6M | +149.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026